Buradasınız

Anasayfa » Content

A REVIEW: CAPSULE SHELL MATERIAL FROM GELATIN TO NON ANIMAL ORIGIN MATERIAL

Journal Name:

  • The International Journal of Pharmaceutical Research and Bio-Science

Publication Year:

  • 2013

Key Words:

Author Name
Abstract (2. Language): 
Capsule is most preferable dosage form. Till now gelatin is widely used as capsule shell material for the preparation of the Hard gelatin capsule and soft gelatin capsule , but due to its animal origin and cross linking property other suitable capsule material that meets the dietary and cultural needs of vegetarian patients and also comply with the regulatory requirement of gelatin need to be invented. Hence various non animal origin materials are synthesis such as hydroxyl propyl methyl cellulose, starch, polyvinyl alcohol copolymer, pullulan etc. and evaluate as a capsule shell material.
Bookmark/Search this post with
FULL TEXT (PDF): 
PDF icon ijprbs_265.pdf
  • 3
42-71
  • Turkish

REFERENCES

References: 

1. Fridrun Podczeck and Brian E jones. 'The history of the medicinal capsule' in Pharmaceutical capsules; 2nd ed. 2004:1.
2. USP 31-NF 26. Rockville, MD: US Pharmacopeial Convention; 2008:1139.
3. Stevens, P.V. (1992). "Unknown". Food Australia 44 (7): 320-324. http://www.gelatin.co.za/gltn1.html.
4. http://en.wikipedia.org/wiki/Gelatin.
5. http://www.rjengineering.com/reach.ht ml.
6. Lippincott Williams and wilkins. 'Oral solid dosage form' in Remington - The Science and Practice of Pharmacy, 21th ed,
Volume - 1: 921.
7. LA Augsburger "Hard and soft gelatin capsules" in Modern Pharmaceutics GS Banker & CT Rhodes, Eds., Marcel Dekker, Inc.: New York, NY, 1995: 395-440.
8. Bond CM, Lees KA, Packington JL. Cephalexin: a new oral broad-spectrum
antibiotic. Pharm J. 1970; 205:210-214.
9. Kontny MJ, Mulski CA. Gelatin capsule brittleness as a function of relative humidity
at room temperature. Int J Pharm. 1989;
54:79-85.
10. Gabriele Reich, 'Formulation and physical properties of soft capsules' available from:
http://www.pharmpress.com.
11. Overholt, S. M.Chewable soft capsules. US Patent 6 258 380, 2001.
12. Lippincott Williams and wilkins. 'Oral solid dosage form' in Remington - The Science and Practice of Pharmacy, 21th ed,
Volume - 1: 923.
13. Dr. Bhawna Bhatt, S.S. Agrawal Pharmaceutical
Technology'Capsules',available from: http://nsdl.niscair.res.in/bitstream
14. Schwier JR, Cooke GG, Hartauer KJ, Yu L. A reactive aldehyde capable of insolubilizing gelatin capsules. Pharm
Technol.1993;17:78-80.
15. Murthy KS, Enders NA, Fawzi MB. Dissolution stability of hard-shell products. Part I. The effect of exaggerated storage conditions. Pharm Technol.1989;13:72-84.
Available Online At www.ijprbs.com
Review Article
Bhavisha Rabadiya, IJPRBS, 2013; Volume 2(3): 42-71
16. Murthy KS, Reisch RG, Fawzi MB. Dissolution stability of hard-shell products. Part II. The effect of dissolution test conditions on in vitro drug release. Pharm.
Technol. 1989;13:53-58.
17. Draper, P. R., Tanner, K. E., Getz, J. J., Burnett, S. and Youngblood, E. Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same. International Patent Application WO 0 103
677.1999.
18. Robert O. Williams III, Matthew A.
Sykora and Vorapann Mahaguna Method to recover a lipophilic drug from hydroxypropyl methyl cellulose matrix tablets. AAPS PharmaSciTech, 2001; 2(2): 8.
19. Shunji Nagata, Advantages to HPMC Capsules: A New Generation's Drug Delivery Technology , 2002; 2(2).
20. Ogura, T., Furuya, Y. and Matsuura, S. HPMC capsules - An alternative to gelatin. Pharm. Technol. Eur.,1998; 10(11): 32,34,36,40,42.
21. Moawia M. Al-Tabakha, HPMC Capsules: Current status and future prospects ,Drug
ISSN: 2277-8713 IJPRBS
development & Delivery , Capsule technology 2002;2(2)
22. I. Chiwele, B.E. Jones, and F. Pdezeck. The shell dissolution of various empty hard capsules. Chem Pharm Bull, 2000; 48: 951¬956.
23. Brown, M. D. Improvements in or relating to encapsulation. International Patent Application WO 9 735 537.1996.
24. N. Hoshi et al., Pharma Tech.
Japan,2003; 19(1): 17-30.
25. N. Hoshi et al, Pharm. Technol. Eur.,
2004; 16(4): 37-46.
26. N. Hoshi, "Abstracts of 2nd Symposium on Formulation Technology" (Tokyo, Japan,
2004) B1-B12.
27. S. Uramatsu et al., "Abstract of 19th Symposium on Particulate Preparations and Designs," (Hakata, Japan, 2002) : 44-47.
28. N. Hoshi, "Abstract of 19th Symposium on Particulate Preparations and Designs," (Hakata, Japan, 2002): 162-167.
29. Noboru Hoshi, Shunji Uramatsu, Toshio Shimamoto, Toshihiro Ogura 'Development
Available Online At www.ijprbs.com
Review Article
Bhavisha Rabadiya, IJPRBS, 2013; Volume 2(3): 42-71
ISSN: 2277-8713
IJPRBS
of PVA Copolymer Capsules' Pharmaceutical Technology Europe Apr 1.2004.
30. Menard, R., Tomka, I., Engel, W. D. and Brocker, E. Process to manufacture starch-containing shaped bodies, mass containing homogenized starch and device to manufacture soft capsules. International Patent Application WO 0 137 817. 1999.
31. Fridrun Podczeck and Brian E jones. 'Formulation and physical properties of soft capsules ' in Pharmaceutical capsules; 2nd
ed. 2004: 210.
32. Watts P, Smith A.TARGIT technology: coated starch capsules for site-specific drug delivery into the lower gastrointestinal tract. Expert Opin Drug Deliv. 2005
Jan;2(1):159-67.
33. http://capsugel.com/

Thank you for copying data from http://www.arastirmax.com